Search for: "Par Pharmaceutical Inc. "
Results 101 - 120
of 171
Sort by Relevance
|
Sort by Date
19 Oct 2011, 11:27 am
Prometheus Laboratories, Inc., the U.S. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
15 Sep 2011, 5:46 am
Attorney's office joined in the lawsuit, brought by Chicago pharmacist Bernard Lisitza in a 162-page complaint Defendants include Par Pharmaceuticals Companies Inc. of Woodcliff Lake, N.J., and two foreign generic drugmakers overcharged the Medicaid program by getting pharmacies to dispense different, more-expensive, dosage forms than what was prescribed. [read post]
9 Sep 2011, 6:56 am
Par Pharmaceutical Cos., 06-6131, US District Court, Northern District of Illinois (Chicago). [read post]
8 Sep 2011, 12:59 pm
Par Pharmaceuticals Under Investigation By U.S. [read post]
7 Sep 2011, 4:05 pm
A qui tam complaint against Par Pharmaceuticals was unsealed yesterday in Chicago. [read post]
7 Sep 2011, 4:22 am
Apotex (Patently-O) Glivec (Imatinib mesylate) – India: The Glivec patent saga – its raining recusals (Spicy IP) Glivec (Imatinib mesylate) – India: Supreme Court to hear Novartis challenge to India’s patent law (IP Watch) Lo Loestrin Fe (Norethindrone acetate / Ethinyl estradiol / Ferrous fumarate) – US: Warner Chilcott files patent infringement complaint against Lupin in response to Para IV certification (Patent Docs) Lumigan (Bimatoprost) – US: Allergan files… [read post]
5 Sep 2011, 9:36 pm
Par Pharmaceutical, Inc. et al. v. [read post]
24 Aug 2011, 12:03 pm
Barr Pharmaceuticals settled a similar case last year and Watson/Schein Pharmaceuticals Inc. reportedly anticipates an imminent settlement. [read post]
14 Aug 2011, 9:59 pm
Par Pharmaceutical Inc. et al. 1:11-cv-00705; filed August 10, 2011 in the District Court of Delaware • Plaintiffs: Avanir Pharmaceuticals Inc.; Avanir Holding Company; Center for Neurologic Study • Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
15 Jun 2011, 4:56 am
Par Pharmaceutical, Inc. [read post]
12 Jun 2011, 9:17 pm
.; Par Pharmaceutical Inc. [read post]
5 May 2011, 1:49 pm
., Inc., 2008 WL 4513696, at *5 (D.N.J. [read post]
4 May 2011, 10:36 am
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
5 Apr 2011, 2:35 pm
Par Pharmaceutical, Inc. [read post]
28 Mar 2011, 2:42 pm
Karst – Late last week, Par Pharmaceutical, Inc. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
6 Feb 2011, 9:34 pm
• Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
3 Jan 2011, 9:45 pm
Nursing Homes: PATIENTS SUFFER SUB-PAR CARE AT CALIFORNIA FACILITIES, CLASS ACTION SAYS, Valentine v. [read post]
